Target intelligence / Profile preview

Staphylococcus aureus cell surface structures

Molecular classification
Polysaccharide, Protein, Lipid, Other
01

Overview

Staphylococcus aureus cell surface structures represent a diverse collection of macromolecules that constitute the bacterial cell envelope, serving as the primary interface between the pathogen and its host. These structures include a thick, cross-linked peptidoglycan layer, wall teichoic acids (WTA), lipoteichoic acids (LTA), and a variety of cell wall-anchored (CWA) proteins, such as Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs) (1.2.1, 1.3.1). Biologically, these components are essential for maintaining cell shape, resisting osmotic pressure, and facilitating critical processes like adhesion to host tissues, biofilm formation, and evasion of the host immune response (1.1.2, 1.2.2). Because of their essentiality and accessibility, these structures are the primary targets for many clinical antibiotics, including beta-lactams and glycopeptides, which inhibit cell wall synthesis (1.1.3, 1.3.5). Furthermore, novel therapeutic strategies are increasingly focusing on specific surface proteins and teichoic acid biosynthetic pathways to address the challenge of multidrug-resistant strains, such as methicillin-resistant S. aureus (MRSA) (1.4.2, 1.4.3).

Other names
Cell wall componentsS. aureus surface antigensCell envelopeCell wall-anchored proteinsMSCRAMMsMicrobial Surface Components Recognizing Adhesive Matrix Molecules
02

Mechanism of action

Inhibition of cell wall synthesis (transpeptidation and transglycosylation), disruption of membrane integrity, inhibition of teichoic acid biosynthesis, and neutralization of surface adhesins (1.1.2, 1.4.1, 1.4.2).

03

Biological functions

Cell wall organizationAdhesionImmune evasionBiofilm formationCation homeostasisStructural integrity
04

Disease associations

InfectionSepsisEndocarditisPneumoniaSkin and soft tissue infectionOsteomyelitis
05

Safety considerations

Antimicrobial resistance (MRSA, VRSA)NephrotoxicityOtotoxicityMyopathyJarisch-Herxheimer reactionDisruption of host microbiome
06

Interacting drugs

Vancomycin

7 more in the full profile.

07

Biomarkers

Staphylococcus aureus Protein A (SpA)Clumping factor A (ClfA)Peptidoglycan fragmentsWall teichoic acid (WTA) levels

Beyond the preview

Go deeper on Staphylococcus aureus cell surface structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus aureus cell surface structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call